MAKING A NEW WAVE WITH
PREDICTIVE BIOMARKERS
We Hope to Make a World Free From Cancer by Developing
First-in-Class Anticancer Drugs Based on Predictive Biomarkers
We Strive to Make
the World Healthier
We develop first-in-class anticancer drugs based on predictive biomarkers for unmet medical needs.
By utilizing clinical information from one of the largest hospital in South Korea, we hope to make a world free from cancer.
Our dedicated researchers are making ceaseless efforts to develop new anticancer drugs.
We will continue to strive for the healthy life of mankind.
Corporate video
Our Scientific Approach
-
Patient Population
-
Biomarker Identification
-
Novel Anticancer Drug
Our researchers are developing predictive biomarkers that could identify patient's drug response to a certain therapy.
As a result, we can shorten the lead time, reduce the development cost and
increase the success rate in first-in-class anticancer drugs.
Press Relese
More-
Wellmarker Bio acquires “Certification of Excellence in Employee Invention Promo...
Wellmarker Bio has recently announced that it has acquired “Certification of Excellence in Employee Invention Promotion” and ...
2022-05-18 -
Wellmarker Bio’s Immunotherapy ‘WM-A1’ gets nominated for the government-led...
Wellmarker Bio announced on May 11, 2022 that its immunotherapeutic antibody "WM-A1", an anti-cancer treatment for Non-Small Cell Lung Cancer ...
2022-05-12 -
Wellmarker Bio and Paik Hospital Ink MoU to develop personalized anticancer drug
Wellmarker Bio(WMBIO) has entered into an agreement with Inje University Paik Hospital to enhance research collaboration for the development o...
2022-04-22